Table 1 Baseline characteristics
All | suPAR < 4 | suPAR 4–6 | suPAR > 6 | P value | |
|---|---|---|---|---|---|
N (%) | 1747 | 804 (46.0) | 514 (29.4) | 429 (24.6) | |
Age median (IQR) | 70 (57–79) | 62 (44–73) | 74 (65–83) | 76 (67–85) | < 0.001 |
Sex (=male %) | 897 (51.4) | 436 (55.2) | 250 (48.6) | 211 (49.2) | 0.08 |
suPAR ng/ml (IQR) | 4.1 (3.3–6.0) | 3.2 (2.9–3.6) | 4.7 (4.3–5.3) | 8.5 (7.1–11.3) | < 0.001 |
CRP ug/ml (IQR) | 3 (3–17) | 3 (3–4) | 4 (3–18) | 20 (5–72) | < 0.001 |
Lymphocyte count 103/ul (IQR) | 7.5 (6.0–9.8) | 7.3 (5.9–8.8) | 7.7 (5.9–9.8) | 8.55 (6.3–12.1) | < 0.001 |
Creatinine (IQR) nmol/ml | 77 (64–96) | 70 (61–83) | 79.5 (65–97) | 101 (74–139) | < 0.001 |
Comorbidities | |||||
Diabetes N (%) | 365 (20.9) | 109 (13.6) | 121 (23.5) | 135 (31.5) | < 0.001 |
Cardiovascular disease N (%) | 1151 (65.9) | 416 (51.7) | 387 (75.3) | 348 (81.1) | < 0.001 |
Neurological disorder N (%) | 516 (29.5) | 209 (26.0) | 156 (30.4) | 151 (35.2) | 0.003 |
Pulmonary disease N (%) | 388 (22.2) | 155 (19.3) | 126 (24.5) | 107 (24.9) | 0.024 |